Latest News

What you need to know for Saturday’s Monumental Marathon

What you need to know for Saturday’s Monumental Marathon

Angeli Kakade | News 8 Daybreak 6

INDIANAPOLIS (WISH) – Thousands of runners will be hitting the pavement Saturday morning for the Monumental Marathon.

According to Beyond Monumental, this is the first year the full marathon, the half marathon, and the 5K race have all sold out.

The sold-out race is bringing a total of nearly 19,000 athletes running through Indianapolis.

Beyond Monumental says the marathon will see its most competitive elite fields ever with some athletes looking to qualify for the 2020 Olympic Team Trials Marathon.

Opening ceremonies for the Monumental Marathon kick off at 7:30 a.m. Saturday with the race starting at 8:00 a.m. near Capital Street and Washington Street.

Even if you’re not taking part in the Monumental Marathon, you may still feel the impact of the race.

Runners will have 6.5 hours to complete the full 26.2 mile course.

During that time, several roads will be closed including as north of McCarty Street, south of 71st Street, as far west as White River Parkway East Drive and as far east as the Indiana State Fairgrounds.

The road closures will happen at various times between 8 a.m. and 3 p.m.

For more information on the road closures, click here and here.


Elanco closes out first full year of independence

GREENFIELD, Ind. (Inside INdiana Business) — Elanco Animal Health Inc. (NYSE: ELAN) is reporting full-year net income of nearly $68 million in 2019, down from $86.5 million the previous year. 2019 marked the first full year for Elanco as an independent, public company. It separated from Indianapolis-based Eli Lilly and Co. (NYSE: LLY) in 2018.

The company is also reporting a fourth-quarter net loss of $9.5 million, compared to net income of $16.4 during the same period a year ago.

Elanco President and Chief Executive Officer Jeff Simmons says the company is moving with “speed and agility” like never before.

“We are advancing our pipeline, executing across a diverse portfolio and improving profitability through a robust productivity agenda,” said Simmons. “We remain confident in the underlying fundamentals in our base business.”

Simmons says the acquisition of Bayer Animal Health is developing better than expected. In August, Elanco announced it was purchasing the animal health assets from Germany-based Bayer AG in a deal valued at $7.6 billion.

“We are encouraged by the progress from a regulatory, financing and integration planning perspective, as well as, Bayer’s underlying market positioning and performance. We continue to look toward a mid-2020 close.”

If approved, it would double Elanco’s Companion Animal business and create the second-largest animal health company by revenue.

To view the complete earnings report, click here.